Regulatory Disclosures

Certain statements contained or incorporated by reference in this disclosure document constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

Forward-looking statements include, without limitation, statements regarding Aevum Zenth Conglomerate's strategy, future operations, projected financial results, anticipated growth opportunities, technology development timelines, regulatory developments, and capital allocation plans. Words such as "anticipates," "believes," "expects," "intends," "projects," "plans," "estimates," "continues," "could," "may," "might," "will," "should," and variations thereof are intended to identify forward-looking statements.

Aevum Zenth undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law. Factors that could cause actual results to differ include, but are not limited to: regulatory changes across multiple jurisdictions, geopolitical instability, technology disruption, supply chain disruptions, foreign exchange fluctuations, litigation outcomes, integration risks from acquisitions, and competitive pressures in each of our 400 subsidiary operating companies.

Aevum Zenth Conglomerate, Inc. (CIK: 0002147083) is registered as an issuer with the U.S. Securities and Exchange Commission. Our filings are available through the SEC's Electronic Data Gathering, Analysis, and Retrieval (EDGAR) system and on our investor relations website.

Investing in Aevum Zenth Conglomerate involves significant risk. The following risk factors should be carefully considered in conjunction with the other information contained in this document and our Annual Report on Form 10-K.

3.1 Business & Operational Risks

• The conglomerate structure across 400+ subsidiaries in diverse industries creates complex operational, management, and integration challenges that could adversely affect performance.
• Significant inter-segment transactions and intercompany dependencies could result in concentrated risk exposure across divisions.
• Failure to achieve expected synergies from acquisitions and strategic investments could materially impact financial results and shareholder value.
• Cybersecurity threats, data breaches, and technology failures across our distributed subsidiary network could result in significant financial, operational, and reputational damage.
• Dependence on key personnel, particularly in technology and aerospace divisions, could disrupt operations if succession planning is inadequate.

3.2 Regulatory & Legal Risks

• Changes in domestic and international trade policies, tariffs, and economic sanctions could materially impact our global operations and supply chains.
• Increasing antitrust scrutiny of large conglomerates in multiple jurisdictions (U.S., EU, UK, China, India) could result in restrictive regulations or forced divestitures.
• Climate change regulations, carbon pricing mechanisms, and environmental compliance requirements may impose significant costs across energy and construction divisions.
• Healthcare regulatory changes, including drug pricing controls and FDA approval processes, could affect pharmaceutical and medical device revenue streams.
• Litigation risks related to product liability, patent disputes, and commercial claims across diverse business operations.

3.3 Financial & Market Risks

• Fluctuations in foreign currency exchange rates across 62 countries could materially impact reported revenues, earnings, and asset valuations.
• Interest rate volatility affects financing costs for capital-intensive operations in energy, aerospace, and real estate divisions.
• Commodity price volatility (energy, metals, agricultural products) could impact margins across multiple subsidiary operations.
• Liquidity risks related to the conglomerate's debt structure, including $42B in outstanding debt across various subsidiaries and holding entities.
• Goodwill and intangible asset impairment risks from acquisition-related write-downs across the subsidiary portfolio.

Aevum Zenth is governed by a board of directors composed of both executive and independent directors, with a majority of independent directors as required by NYSE listing standards. The board oversees corporate strategy, risk management, executive compensation, and governance matters across all subsidiary operations.

Board Committees

Aevum Zenth maintains a zero-tolerance policy toward bribery, corruption, and illicit payments in all jurisdictions where we operate. Our anti-corruption program is designed to ensure compliance with the U.S. Foreign Corrupt Practices Act (FCPA), the UK Bribery Act 2010, and applicable anti-corruption laws in all 62 countries of operation.

Program Components

• Third-Party Due Diligence: All intermediaries, agents, distributors, and joint venture partners undergo risk-based due diligence before engagement and annual re-assessment.
• Gifts & Hospitality Policy: Strict limits on gifts, meals, travel, and entertainment for government officials. All interactions with public officials require pre-approval from the Chief Compliance Officer.
• Charitable Contributions & Political Donations: All charitable contributions require legal review. Political contributions are made only through lawful corporate channels and in compliance with applicable campaign finance laws.
• Accounting Controls: Books and records are maintained with accuracy and transparency. No off-balance-sheet arrangements or undisclosed accounts are permitted.
• Training & Certification: All 340,000+ employees complete annual FCPA compliance training. Employees in high-risk jurisdictions undergo enhanced training and must certify compliance annually.
• Reporting Mechanisms: Anonymous reporting via third-party hotline available in 30+ languages. Non-retaliation policy protects all reporters.

Aevum Zenth maintains rigorous sanctions screening and export control programs to ensure compliance with applicable sanctions regimes, including but not limited to the Office of Foreign Assets Control (OFAC) Sanctions Programs, Bureau of Industry and Security (BIS) Export Administration Regulations (EAR), European Union sanctions regulations, United Nations Security Council sanctions, and UK Office of Sanctions Implementation.

All subsidiaries are required to screen customers, suppliers, partners, and transactions against applicable sanctions lists before entering into or continuing any business relationship. Violations are reported to the Chief Compliance Officer and, where required by law, to relevant authorities.

Aevum Zenth publishes annual ESG reports in alignment with the Task Force on Climate-related Financial Disclosures (TCFD), Sustainability Accounting Standards Board (SASB), Global Reporting Initiative (GRI), and the European Union's Corporate Sustainability Reporting Directive (CSRD). Our ESG data is externally assured by an independent third-party assurance provider.

Environmental Metrics (FY2025)

Social Metrics

• Diversity: 48% of workforce identifies as female; 42% of board members are women; 38% of senior leadership are from underrepresented groups.
• Employee Safety: Total recordable incident rate (TRIR) of 0.42 across all operations, below industry average of 1.8.
• Training: Average of 52 hours of training per employee annually, including compliance, diversity & inclusion, and technical skills development.
• Community Investment: $280M in charitable contributions and community programs across 62 countries in FY2025.

Aevum Zenth processes personal data of employees, customers, suppliers, and end-users across its global operations. Our data protection framework ensures compliance with the EU General Data Protection Regulation (GDPR), the California Privacy Rights Act (CPRA), the UK GDPR, and data protection laws in all other jurisdictions of operation.

Data Protection Framework

• Data Protection Officer (DPO): A centralized DPO function oversees privacy compliance across all subsidiaries. Regional DPOs are appointed in the EU, UK, and APAC.
• Lawful Basis: All data processing activities are mapped to applicable lawful bases under Article 6 GDPR. Special category data requires Article 9 lawful basis.
• Data Transfer Mechanisms: Cross-border transfers utilize EU Standard Contractual Clauses (SCCs), UK International Data Transfer Agreements (IDTAs), or adequacy decisions as applicable.
• Data Subject Rights: Established procedures enable data subjects to exercise rights of access, rectification, erasure, portability, and objection within statutory timeframes.
• Data Breach Response: Incident response protocols ensure notification to supervisory authorities within 72 hours of awareness and to affected data subjects where required.
• Privacy by Design: Privacy impact assessments (PIAs/DPIAs) are mandatory for all new products, services, and processing activities.

Aevum Zenth is subject to various legal proceedings, claims, investigations, and regulatory matters that arise in the ordinary course of business. The following represents material pending proceedings as of the date of this filing.

Material Litigation

• Aevum Healthcare Patent Litigation: Multiple patent infringement actions pending in the U.S. District Court (ND Cal.) and EPO related to gene therapy technologies. Management estimates a reasonably possible loss range of $120M-$180M and has recorded a provision at the low end of the range. The company believes it has strong defenses and intends to defend vigorously.
• Aerospace Contract Dispute: Dispute with a government defense contractor over a $2.4B satellite constellation contract. The subsidiary claims additional costs due to scope modifications. Legal counsel advises a probable recovery of $800M-$1.2B. Management has filed counterclaims.
• Agricultural Division Environmental Matter: EPA enforcement action regarding pesticide discharge at two facilities in the U.S. Midwest. Settlement discussions are ongoing with a potential range of $15M-$25M including remediation costs.
• Employment Class Action: Pending class action in the UK High Court regarding alleged wage disparities across legacy acquired entities. Provision of £8M has been recorded. Management disputes the allegations.

Aevum Zenth Conglomerate prepares its consolidated financial statements in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP) as issued by the Financial Accounting Standards Board (FASB), as codified in the Financial Accounting Standards Board Accounting Standards Codification (ASC). Financial statements of certain international subsidiaries are prepared under International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB) and consolidated through a GAAP-to-IFRS adjustment process.

Recent Accounting Standards Adoption

Aevum Zenth requires all tier-1 suppliers to comply with the Aevum Zenth Supplier Code of Conduct, which covers labor practices, human rights, environmental stewardship, business ethics, and cybersecurity. The code is contractually binding and forms part of all procurement agreements.

• Due Diligence: All new suppliers undergo human rights and environmental due diligence per the UN Guiding Principles on Business and Human Rights and OECD Due Diligence Guidance.
• Conflict Minerals: Aevum Zenth is compliant with Section 1502 of the Dodd-Frank Act. Our 2025 Conflict Minerals Report is available on our investor relations website and confirms that our products do not contain conflict minerals from the Democratic Republic of the Congo or adjoining countries.
• Modern Slavery: In compliance with the UK Modern Slavery Act 2015 and California Transparency in Supply Chains Act, our annual Modern Slavery Statement is published annually and details steps taken to prevent modern slavery in our operations and supply chain.
• Carbon Footprint: Scope 3 emission targets for suppliers include 50% of tier-1 suppliers by revenue setting science-based targets by 2028.

Aevum Zenth's tax strategy is governed by the principle of substantive economic activity in all jurisdictions of operation. We do not engage in artificial profit shifting or aggressive tax avoidance structures. Our tax affairs are conducted in compliance with the laws of all 62 jurisdictions and in accordance with OECD BEPS (Base Erosion and Profit Shifting) recommendations.

• Effective Tax Rate: Consolidated effective tax rate for FY2025 was 21.3%, reflecting the geographic distribution of earnings across jurisdictions.
• Tax Transparency: Country-by-country reporting (CbCR) is published in compliance with EU CbCR Directive and OECD BEPS Action 13.
• GILTI & FDII: Aevum Zenth has implemented compliance programs for U.S. GILTI (Global Intangible Low-Taxed Income) and FDII (Foreign-Derived Intangible Income) provisions.
• Global Minimum Tax: Aevum Zenth is preparing for the OECD Pillar Two global minimum tax of 15% effective January 1, 2026, with adequate income inclusion rules (IIR) and undertaxed payments rules (UTPR) implementation.